- Home
- BRNS vs RFL Comparison
BRNS vs RFL Comparison
Compare BRNS & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- RFL
- Stock Information
- Founded
- BRNS 2016
- RFL 2017
- Country
- BRNS United Kingdom
- RFL United States
- Employees
- BRNS N/A
- RFL N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- RFL Real Estate
- Sector
- BRNS Health Care
- RFL Finance
- Exchange
- BRNS Nasdaq
- RFL Nasdaq
- Market Cap
- BRNS 52.0M
- RFL 48.4M
- IPO Year
- BRNS 2021
- RFL N/A
- Fundamental
- Price
- BRNS $1.17
- RFL $2.40
- Analyst Decision
- BRNS Strong Buy
- RFL
- Analyst Count
- BRNS 2
- RFL 0
- Target Price
- BRNS $4.00
- RFL N/A
- AVG Volume (30 Days)
- BRNS 38.8K
- RFL 65.0K
- Earning Date
- BRNS 11-07-2024
- RFL 12-12-2024
- Dividend Yield
- BRNS N/A
- RFL N/A
- EPS Growth
- BRNS N/A
- RFL N/A
- EPS
- BRNS N/A
- RFL N/A
- Revenue
- BRNS N/A
- RFL $540,000.00
- Revenue This Year
- BRNS $27.18
- RFL N/A
- Revenue Next Year
- BRNS N/A
- RFL N/A
- P/E Ratio
- BRNS N/A
- RFL N/A
- Revenue Growth
- BRNS N/A
- RFL 92.86
- 52 Week Low
- BRNS $1.11
- RFL $1.29
- 52 Week High
- BRNS $5.10
- RFL $2.44
- Technical
- Relative Strength Index (RSI)
- BRNS 40.45
- RFL 87.25
- Support Level
- BRNS $1.15
- RFL $2.00
- Resistance Level
- BRNS $1.35
- RFL $1.94
- Average True Range (ATR)
- BRNS 0.07
- RFL 0.10
- MACD
- BRNS 0.00
- RFL 0.03
- Stochastic Oscillator
- BRNS 14.29
- RFL 94.85
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.